Monteluke EBS 10/10mg Tablet 10s

Monteluke EBS 10/10mg Tablet 10s combines two complementary anti‑allergy medicines into a single daily dose. Ebastine is a second‑generation H1 antihistamine designed to relieve allergy symptoms without the marked drowsiness seen with older antihistamines. Montelukast is a leukotriene receptor antagonist that reduces inflammation and narrowing in the airways by blocking leukotrienes, chemicals involved in allergic and asthma‑related responses.

This combination is particularly useful in people whose allergies affect both the upper airway (nose, sinuses, eyes) and, to a lesser extent, the lower airway (mild allergic asthma or nighttime cough). It is typically prescribed as a preventive or controller medicine, taken every day during allergy seasons or longer in perennial allergic rhinitis. While Monteluke EBS 10/10mg Tablet 10s can improve asthma‑related symptoms when used as part of a larger plan, it must not replace inhaled steroids or quick‑relief inhalers in moderate or severe asthma, and it has no role in treating viral infections, sepsis, meningitis, tuberculosis, or chronic conditions like diabetes, hypertension, rheumatoid arthritis, or dementia.

Monteluke EBS 10/10mg Tablet 10s should be used only for clearly allergy‑related conditions. It is not meant for common cold, influenza, dengue, chikungunya, COVID‑like viral fevers, or non‑allergic stomach complaints such as irritable bowel syndrome or simple acidity.

Main uses include

Allergic rhinitis (seasonal and perennial): Treatment and prevention of sneezing, nasal itching, runny nose, nasal congestion, and itchy, watery eyes triggered by pollen, dust mites, animal dander, or mould.

Allergic rhinitis with mild asthma

In patients who have both nasal allergies and mild persistent asthma, Monteluke EBS 10/10mg Tablet 10s helps control upper airway symptoms and can reduce allergy‑related wheeze or nighttime cough as part of a complete asthma regimen.

Chronic or recurrent allergy symptoms

Used as maintenance therapy in people who experience frequent or year‑round allergy flares to reduce the intensity and frequency of episodes.

Allergy‑related cough/post‑nasal drip

It may help in selected patients whose persistent cough is mainly due to allergic post‑nasal drip, though it is not a primary cough suppressant and does not treat infections like bronchitis or pneumonia.

Monteluke EBS 10/10mg Tablet 10s is not indicated for: acute asthma attacks, bacterial infections (pneumonia, bacterial skin infections, sinusitis due to bacteria), serious systemic illnesses (sepsis, meningitis, encephalitis), or chronic non‑allergic diseases such as diabetes, hypertension, coronary artery disease, stroke, osteoarthritis, osteoporosis, psoriasis, acne, or eczema not driven by allergy.

• Dual mechanism: Ebastine blocks histamine‑mediated itching, sneezing, and runny nose, while Montelukast blocks leukotriene‑mediated swelling and airway narrowing, offering broader control than many single‑agent antihistamines.

• Once‑daily dosing: Both components act for around 24 hours, improving convenience and adherence, particularly in patients needing regular therapy.

• Low sedation: Ebastine is generally non‑drowsy, so most people can continue working, studying, or driving; a few may still notice mild fatigue.

• Upper and lower airway benefits: Helpful in patients with both allergic rhinitis and mild allergic asthma, especially when nighttime cough and wheeze are linked to allergy.

• Possible steroid‑sparing effect: In some cases, better allergy control may allow lower doses of nasal or inhaled steroids, although these medicines are rarely replaced completely.

Most side effects are mild and short‑lived; serious reactions are uncommon but important to recognise.

Common side effects

• Headache or mild dizziness.

• Stomach discomfort, nausea, or mild heartburn.

• Dry mouth or mild sore throat.

• Tiredness or a “low‑energy” feeling (less common than with older antihistamines).

Uncommon side effects

• Diarrhoea or constipation.

• Skin rash, itching, or hives.

• Palpitations or a sensation of a fast heartbeat.

• Mild mood changes, irritability, restlessness, or sleep disturbance.

Rare but serious side effects (seek urgent medical help)

• Severe allergic reaction: swelling of face, lips, tongue, or throat; difficulty breathing; widespread or blistering rash.

• Significant mood or behaviour changes: new or worsening anxiety, depression, aggressive behaviour, sleepwalking, or suicidal thoughts (reported mainly with Montelukast).

• Severe chest tightness or breathlessness: could indicate uncontrolled asthma or another serious problem; Monteluke EBS 10/10mg Tablet 10s is not a rescue treatment.

• Marked palpitations, fainting, or severe dizziness.

• Take Monteluke EBS 10/10mg Tablet 10s once daily, exactly as prescribed. Many doctors prefer evening dosing, especially when nighttime symptoms are troublesome, but follow your specific instructions.

• Swallow the dose with water, with or without food; taking it after a light meal may reduce stomach upset.

• Try to take it at the same time each day for steady control of symptoms.

• Do not change the dose, stop suddenly, or use it only “when needed” without discussing with your doctor, especially if it is part of your asthma or allergy plan.

• In children, only use if a doctor has recommended it, with age‑appropriate dosing; do not split or share adult tablets on your own.

Monteluke EBS 10/10mg Tablet 10s targets two main chemical pathways in allergy and asthma‑related inflammation:

Ebastine: a second‑generation H1 histamine receptor antagonist. When allergens trigger histamine release, histamine binds to H1 receptors and causes itching, sneezing, a runny nose, and watery eyes. Ebastine blocks these receptors, reducing these symptoms with minimal penetration into the brain, so it tends to be less sedating than older antihistamines.

Montelukast: a cysteinyl‑leukotriene (CysLT1) receptor antagonist. Leukotrienes cause swelling of the airway lining, increased mucus, and tightening of airway muscles. By blocking CysLT1 receptors, Montelukast reduces this inflammation and bronchoconstriction, helping with allergy‑related asthma symptoms and supporting control of nasal congestion.

Together, these actions calm allergic inflammation in both the upper and lower airways, improving breathing comfort and reducing day‑to‑day symptoms in appropriately selected patients.

• Think of Monteluke EBS 10/10mg Tablet 10s as a controller medicine: it works best when taken regularly, especially during allergy seasons or in persistent allergic rhinitis.

• If you have asthma, never stop inhaled steroids or reliever inhalers on your own just because you feel better; any step‑down should be planned with your doctor.

• Pay attention to mood or behaviour changes in yourself or your child after starting this medicine; report new anxiety, depression, sleep problems, or unusual behaviour promptly.

• Combine medication with lifestyle strategies—dust‑proofing the bedroom, using saline nasal rinses, avoiding cigarette smoke, and limiting exposure to known triggers can significantly reduce symptom burden.

• Do not use Monteluke EBS 10/10mg Tablet 10s for unexplained fever, chest pain, or breathlessness; serious conditions like pneumonia, heart attack, pulmonary embolism, or sepsis need urgent medical assessment and different treatments.

• Food: No significant interaction; may be taken with or after meals.
• Grapefruit/citrus juices: Usual amounts are unlikely to cause problems, but very large quantities could theoretically alter the metabolism of some antihistamines; keep intake moderate.
• Alcohol: Can increase the risk of feeling drowsy or dizzy; better to limit or avoid, particularly when starting therapy or if you need to drive.

• Other antihistamines: Combining with additional antihistamines can increase side effects without improving efficacy; avoid taking “cold and allergy” products on top of Monteluke EBS 10/10mg Tablet 10s unless your doctor approves.

• Strong enzyme‑modifying drugs (some antifungals, certain antibiotics, anti‑seizure medicines): May affect the breakdown of Ebastine or Montelukast; your doctor will review your full list of medicines.

• Warfarin or other blood thinners: Significant interaction is uncommon, but always tell your doctor about long‑term treatments so routine monitoring can be adjusted if needed.

• Asthma medicines: Monteluke EBS 10/10mg Tablet 10s is usually safe and often intentionally combined with inhaled corticosteroids and bronchodilators; never alter inhaler doses without medical advice.

• Asthma: Helpful as a controller in allergy‑related mild asthma but not sufficient alone in moderate or severe disease or during acute attacks.
• Liver disease: Both components are metabolised in the liver; in significant liver impairment or cirrhosis, your doctor may choose alternatives or use Monteluke EBS 10/10mg Tablet 10s with extra caution.
• Heart disease/arrhythmias: Generally safe in most patients, but those with serious rhythm problems or unstable coronary artery disease should be reviewed individually.
• Psychiatric/neurological disorders: In patients with pre‑existing depression, anxiety, bipolar disorder, or seizure disorders, any mood or behavioural change after starting Montelukast should prompt review.

If you miss a dose and remember on the same day, take it as soon as you remember. If it is nearly time for the next dose, skip the missed one and continue your usual schedule the following day. Do not take a double dose to “catch up”, as this can increase side effects such as headache, stomach upset, or palpitations without improving symptom control. If you often forget doses and your symptoms are poorly controlled, speak with your doctor about reminder methods or alternate strategies.